{"url":"https://lda.senate.gov/api/v1/filings/dc010fcd-adf2-4f68-8adb-bc7f746f7705/","filing_uuid":"dc010fcd-adf2-4f68-8adb-bc7f746f7705","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2018,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/dc010fcd-adf2-4f68-8adb-bc7f746f7705/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David Stewart","dt_posted":"2018-10-22T18:36:54.357000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"One Federal Place","registrant_address_2":"1819 North 5th Avenue","registrant_different_address":false,"registrant_city":"Birmingham","registrant_state":"AL","registrant_zip":"35203","registrant":{"id":36914,"url":"https://lda.senate.gov/api/v1/registrants/36914/","house_registrant_id":30590,"name":"BRADLEY ARANT BOULT CUMMINGS LLP","description":"Law firm","address_1":"1819 North 5th Avenue","address_2":"One Federal Place","address_3":null,"address_4":null,"city":"Birmingham","state":"AL","state_display":"Alabama","zip":"35203","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RYAN ROBICHAUX","contact_telephone":"+1 205-521-8000","dt_updated":"2026-07-30T15:06:38.946120-04:00"},"client":{"id":145978,"url":"https://lda.senate.gov/api/v1/clients/145978/","client_id":1004467,"name":"SERINA THERAPEUTICS, INC.","general_description":"Pharmaceutical","client_government_entity":false,"client_self_select":null,"state":"AL","state_display":"Alabama","country":"US","country_display":"United States of America","ppb_state":"AL","ppb_state_display":"Alabama","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-10-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Opioids; FY19 Labor-HHS Appropriations (S. 3158, H.R. 6470, H.R. 6157), research funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59827,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"STEWART","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, Senator Jeff Sessions","new":false},{"lobbyist":{"id":66668,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"KAVINOKY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Representative George Nethercutt; Deputy Chief of Staff, Representative Richard Pombo","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}